|
LUIGI VIGORÉ1, GIUSY MESSINA2, FERNANDO
BRIVIO3, LUCA FUMAGALLI3, FRANCO ROVELLI4,
GIUSEPPE DI FEDE4 and PAOLO LISSONI4
Abstract
Background: At present, it is known that cancer-related
immunosuppression would mainly depend on an immunosuppressive
action mediated by a subtype of CD4+ lymphocytes, the
so-called regulatory T lymphocytes (T-reg), which are identified
as CD4+CD25+ cells.
Moreover, it has been shown that anticancer immunity is under
psychoneuroendocrine regulation, mainly mediated by the pineal
hormone melatonin (MLT).
This study was performed to investigate the in vivo and in vitro
effects of MLT on T-reg generation.
Materials and Methods: We evaluated the in vivo
effects of MLT (20 mg/daily orally in the evening) in 20
patients with untreatable metastatic solid tumor and the in
vitro effects of MLT incubation (at 10 and 100 pg/ml) of pure
lymphocyte cultures on T-reg cell count.
Results: MLT induced a statistically significant
decline in mean T-reg cell numbers in patients who achieved
disease control, whereas no effect was seen in those who had
progressed. In contrast, no in vitro effect of MLT incubation
was apparent.
Conclusion: This preliminary study would suggest that
MLT may exert in vivo an inhibitory action on T-reg cell
generation in cancer patients which is associated with a control
of the neoplastic progression, whereas no direct effect was seen
in vitro on lymphocyte differentiation. This finding would
suggest that MLT may counteract T-reg cell generation in vivo by
inhibiting macrophage activity which is involved in stimulating
T-reg cell production.
|